Skip to main content
Log in

Current pathogenetic and molecular concepts in viral liver carcinogenesis

  • Published:
Virchows Archiv B

Summary

Hepatocellular carcinoma (HCC) is one of the most frequent malignancies in humans and in most cases a consequence of chronic infection of the liver by hepatotropic viruses (Hepatitis B Virus (HBV) and possibly Hepatitis C Virus (HCV)). Formation of HCC results from a stepwise process involving different preneoplastic lesions that reflect multiple genetic events, like protooncogene activation, tumor suppressor gene inactivation, and growth factor overor reexpression. Recent investigations have gained new insights into how these factors are activated and may interact. In addition, improved knowledge of the molecular biology of HBV has led to better understanding of its pleiotropic effects on induction and progression in hepatocarcinogenesis

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Aaronson SA (1991) Growth factors and cancer. Science 254:1146–1153

    PubMed  CAS  Google Scholar 

  • Adams JM, Cory S (1991) Transgenic models of tumor development. Science 254:1161–1167

    PubMed  CAS  Google Scholar 

  • Anthony PP (1976) Precursor lesions for liver cancer in humans. Cancer Res 36:2579–2582

    PubMed  CAS  Google Scholar 

  • Arakawa M, Kage M, Sugihara S, Nakashima T, Suenaga M, Okuda K (1986 a) Emergence of malignant lesions within an adenomatous hyperplastic nodule in a cirrhotic liver: observations in five cases. Gastroenterology 91:198–208

    PubMed  CAS  Google Scholar 

  • Arbuthnot P, Kew M, Fritsch W (1991)c-fos andc-myc oncoprotein expression in human hepatocellular carcinomas. Anticancer Res 11:921–924

    PubMed  CAS  Google Scholar 

  • Baker SJ, Markowitz S, Fearon ER, Wilson JKV, Vogelstein B (1990) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912–915

    PubMed  CAS  Google Scholar 

  • Bandara LR, Adamczewski JP, Hunt T, La Thangue NB (1991) Cyclin A and the retinoblastoma gene product complex with a common transcription factor. Nature 352:249–251

    PubMed  CAS  Google Scholar 

  • Bauer-Hofmann R, Buchmann A, Wright AS, Schwarz M (1990) Mutations in the Ha-ras proto-oncogene in spontaneous and chemically induced liver tumours of the CFI mouse. Carcinogenesis 11:1875–1877

    PubMed  CAS  Google Scholar 

  • Beasley RP, Lin CC, Hwang LY, Chien CS (1981) Hepatocellular carcinomas and hepatitis B virus: a prospective study of 22707 men in Taiwan. Lancet II: 1129–1133

    Google Scholar 

  • Behrens J, Mareel MM, Roy FM van, Birchmeier W (1989) Dissecting tumor cell invasion; epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 108:2435–2447

    PubMed  CAS  Google Scholar 

  • Ben David Y, Bernstein A (1991) Friend virus-induced erytheoleukemia and the multistage nature of cancer. Cell 66:831–834

    PubMed  CAS  Google Scholar 

  • Benbrook D, Lernhardt E, Pfahl H (1988) A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature 333:669–672

    PubMed  CAS  Google Scholar 

  • Biggs J, Hersperger E, Steeg PS, Liotta LA, Shearn A (1990) ADrosophila gene that in homologous to a mammalian gene associated with tumor metastasis codes for a nucleoside diphosphate kinase. Cell 63:933–940

    PubMed  CAS  Google Scholar 

  • Bishop JM (1991) Molecular themes in oncogenesis. Cell 64:235–248

    PubMed  CAS  Google Scholar 

  • Braun L, Goyette M, Yaswen P, Thompson NL, Fausto N (1987) Growth in culture and tumorigenicity after transfection withras oncogene of liver epithelial cells from carcinogen-treated rats. Cancer Res 47:4116–4124

    PubMed  CAS  Google Scholar 

  • Brechot C, Pourcel C, Louise A, Rain B, Tiollais P (1980) Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 286:533–535

    PubMed  CAS  Google Scholar 

  • Brenner DA, Koch KS, Leffert HL (1989) Transforming growth factor stimulates proto-oncogene c-jun expression and a mitogenic program in primary cultures of adult rat hepatocytes. DNA 8:279–285

    PubMed  CAS  Google Scholar 

  • Bressac B, Galvin KM, Liang TJ, Isselbacher KJ, Wands JR, Ozturk M (1990) Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci USA 87:1973–1977

    PubMed  CAS  Google Scholar 

  • Bressac B, Kew M, Wands J, Ozturk M (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429–431

    PubMed  CAS  Google Scholar 

  • Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, Ventura M, Vall M, Bruguera M, Bru C, et al (1989) Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 11:1004–1006

    Google Scholar 

  • Buendia MA, Etiemble J, Degott C, Babinet C, Tiollais P (1991) Primary hepatocellular carcinoma in transgenic mice carrying a woodchuck c-myc gene activated by hepadnaviral insertion. In: Ciliberto C, Cortese R, Schibler U, Schütz G (eds) Gene expression during liver differentiation and disease. IRBM p 187

  • Buetow KH, Murray JC, Israel JL, London WT, Smith M, Kew M, Blanquet V, Brechot C, Redeker A, Gonvindarajah S (1989) Loss of hepatozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci USA 86:8852–8856

    PubMed  CAS  Google Scholar 

  • Cantely LC, Anger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Soltoff S (1991) Oncogenes and signal transduction. Cell 64:281–302

    Google Scholar 

  • Cariani E, Lasserre C, Seurin D, Hamelin B, Kemeny F, Franco D, Czech MP, Ullrich A, Brechot C (1988) Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors and liver cirrhosis. Cancer Res 48:6844–6849

    PubMed  CAS  Google Scholar 

  • Cariani E, Lasserre C, Kemeny F, Franco D, Brechot C (1991) Expression of insulin-like growth factor II, fetoprotein and hepatitis B virus transcripts in human primary liver cancer. Hepatology 13:644–649

    PubMed  CAS  Google Scholar 

  • Carmichael DF, Sommer A, Thompson RC, Anderson DC, Smith CG, Welgus HG, Stricklin GP (1986) Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci USA 83:2407–2411

    PubMed  CAS  Google Scholar 

  • Caselmann WH, Meyer M, Kekule AS, Lauer U, Hofschneider PH, Koshy R (1990) A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma. Proc Natl Acad Sci USA 87:2970–2974

    PubMed  CAS  Google Scholar 

  • Chakraborty PR, Ruiz-Opazo N, Shouval D, Shafritz DA (1980) Identification of integrated hepatitis B virus DNA and expression of viral RNA in HBsAG-producing human hepatocellular carcinoma cell line. Nature 286:531–533

    PubMed  CAS  Google Scholar 

  • Chandar N, Lombardi B, Locker J (1989) C-myc gene amplification during hepatocarcinogenesis by a choline-devoid diet. Proc Natl Acad Sci USA 86:2703–2707

    PubMed  CAS  Google Scholar 

  • Cheah MSC, Wallace CD, Hoffman RM (1984) Hypomethylation of DNA in human cancer cells: a site-specific change in the c-myc oncogene. J Natl Cancer Inst 73:1057–1065

    PubMed  CAS  Google Scholar 

  • Chisari F, Klopchin K, Morijama T, Pasquinelli C, Dunsford HA, Sell S, Pinkert CA, Brinster RL, Palmiter RD (1989) Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59:1145–1156

    PubMed  CAS  Google Scholar 

  • Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a bloodborne non-A, non-B viral hepatitis genome. Science 244:359–362

    PubMed  CAS  Google Scholar 

  • Colgrove R, Simon G, Ganem D (1989) Transcriptional activation of homologous and heterologous genes by the hepatitis B virus gene product in cells permissive for viral replication. J Virol 63:4019–4026

    PubMed  CAS  Google Scholar 

  • Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA, Dioguardi N, Houghton M (1989) Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet II: 1006–1008

    Google Scholar 

  • Corcos D, Defer N, Raymoundjean M, Paris B, Corral M, Tichonicky L, Kruh J (1984) Correlated increase of the expression of the c-ras gene in chemically induced hepatocarcinomas. Biochem Biophys Res Commun 122:259–264

    PubMed  CAS  Google Scholar 

  • Corral M, Tichonicky L, Guguen-Guillouzo C, Corcos D, Raymondgean M, Paris B, Kruh J, Defer N (1985) Expression of c-fos oncogene during hepatocarcinogenesis, liver regeneration and in synchronized HTC cells. Exp Cell Res 160:427–434

    PubMed  CAS  Google Scholar 

  • Cote GJ, Chiu JF (1987) The expression of oncogenes and liver specific genes in Morris hepatomas. Biochem Biophys Res Commun 143:624–629

    PubMed  CAS  Google Scholar 

  • Cross M, Dexter TM (1991) Growth factors in development, transformation and tumorigenesis. Cell 64:271–280

    PubMed  CAS  Google Scholar 

  • Cullen JM, Marion PL, Sherman GJ, Hong X, Newbold JE (1990) Hepatic neoplasms in aflatoxin B1 treated, congenital duck hepatitis B virus-infected, and virus-free Peking ducks. Cancer Res 50:4072–4080

    PubMed  CAS  Google Scholar 

  • Daughaday WM, Wu J-C, Lee S-D, Kapadia M (1990) Abnormal processing of pro-IGF-II in patients with hepatoma and in some hepatitis B virus antibody-positive asymptomatic individuals. J Lab Clin Med 115:555–562

    Google Scholar 

  • Davis M, Portmann B, Searle M, Wright R, Williams R (1975) Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives. BMJ 4:496–498

    PubMed  CAS  Google Scholar 

  • Dejean A, Sonigo P, Wain-Hobson S, Tiollais P (1984) Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat. Proc Natl Acad Sci USA 81:5350–5354

    PubMed  CAS  Google Scholar 

  • Dejean A, Bougueleret L, Grzeschik KH, Tiollais P (1986) Hepatitis B virus DNA integration in a sequence homologous to v-erbA and steroid receptor genes in a hepatocellular carcinoma. Nature 322:70–72

    PubMed  CAS  Google Scholar 

  • Derynck R, Goeddel DV, Ullrich A, Gutterman JK, Williams RD, Bringman TS, Berger NM (1987) Synthesis of messenger RNAs for transforming growth factor and β and the epidermal growth factor receptor by human tumors. Cancer Res 47:707–712

    PubMed  CAS  Google Scholar 

  • DeThe H, Marchio A, Tiollais P, Dejean A (1987) A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma. Nature 330:667–670

    CAS  Google Scholar 

  • De Vos R, Desmet VJ (1991) Ultrastructural identification of novel hepatic epithelial cells. Hepatology 14:100A

    Google Scholar 

  • Di Bisceglie AM, Rustgi VK, Hoofnagle JM, Dusheiko JM, Lotze MT (1988) Hepatocellular carcinoma. Ann Intern Med 108:390–401

    PubMed  Google Scholar 

  • Di Stasi M, Sbolli G, Fornari F, Cavanna L, Civardi G, Rossi S, Buscarini E, Buscarini L (1990) Hepatocellular carcinoma associated with other primary malignancies. Eur J Cancer 26:649–650

    Google Scholar 

  • Dubois N, Bennoun M, Allemand I, Molina T, Grimber G, Daudet-Monsac M, Abelanet R, Briand P (1991) Time course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice. J Hepatol 13:227–239

    PubMed  CAS  Google Scholar 

  • Dunn WA, Hubbard AL (1984) Receptor-mediated endocytosis of epidermal growth factor by hepatocytes in the perfused rat liver: ligand and receptor dynamics. J Cell Biol 98:2148–2159

    PubMed  CAS  Google Scholar 

  • Edman JC, Gray P, Valenzuela P, Rall LB, Rutter WJ (1980) Integration of hepatitis B virus sequences and their expression in a human hepatoma cell line. Nature 286:535–538

    PubMed  CAS  Google Scholar 

  • Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48900 necropsies. Cancer 7:462–503

    PubMed  CAS  Google Scholar 

  • Eriksson S, Carlson J, Velez R (1986) Risk of cirrhosis and primary liver cancer in alpha-1-antitrypsin deficiency. N Engl J Med 314:736–739

    PubMed  CAS  Google Scholar 

  • Esumi M, Aritaka T, Arii M, Suzuki K, Tanikawa K, Mizuo H, Mimaby T, Shikata T (1986) Clonal origin of human hepatoma determined by integration of hepatitis B virus DNA. Cancer Res 46:5767–5771

    PubMed  CAS  Google Scholar 

  • Etiemble J, Möröy T, Jacquemin E, Tiollais P, Buendia MA (1989) Fused transcripts of c-myc and a new cellular locus,hcr in a primary liver tumor. Oncogene 4:51–57

    PubMed  CAS  Google Scholar 

  • Faktor O, Shaul Y (1990) The identification of hepatitis B virus X gene responsive elements reveals functional similarity of X and HLTV-I tax. Oncogene 5:867–872

    PubMed  CAS  Google Scholar 

  • Farber E, Sarma DSR (1987) Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest 56:4–22

    PubMed  CAS  Google Scholar 

  • Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767

    PubMed  CAS  Google Scholar 

  • Finlay CA, Minds PW, Levine AL (1989) The p53 proto-oncogene can act as a suppressor of transformation. Cell 57:1083–1093

    PubMed  CAS  Google Scholar 

  • Fourel G, Trepo C, Bougueleret L, Henglein B, Ponzetto A, Tiollais P, Buendia MA (1990) Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature 347:294–298

    PubMed  CAS  Google Scholar 

  • Fu XX, Su CY, Lee Y, Hintz R, Biempica L, Snyder R, Rogler CE (1988) Insulin-like growth factor II expression and oval cell proliferation associated with hepatocarcinogenesis in woodchuck hepatitis virus carriers. J Virol 62:3422–3430

    PubMed  CAS  Google Scholar 

  • Fujimori M, Tokino T, Hino O, Kitagawa T, Imamura T, Okamoto E, Mitsunobu M, Ishikawa T, Nakagama H, Harada H, et al. (1991) Allelotype study of primary hepatocellular carcinoma. Cancer Res 51:89–93

    PubMed  CAS  Google Scholar 

  • Fukuda Y, Imoto M, Koyama Y, Miyazawa Y, Nakano I, Hattori M, Urano F, Kodama S, Iwata K, Hayakawa T (1991) Immunohistochemical study on tissue inhibitors of metalloproteinases in normal and pathological human livers. Gastroenterol Jpn 26:37–41

    PubMed  CAS  Google Scholar 

  • Funato T, Yokota J, Sakamoto M, Kameya T, Fukushima S, Ito N, Terada M, Sugimura T (1987) Activation of N-ras gene in a rat hepatocellular carcinoma induced by Dibutylnitrosamine and butylated Hydroxytoluene. Jpn J Cancer Res 78:689–694

    PubMed  CAS  Google Scholar 

  • Furuya K, Nakamura M, Yamamoto Y, Togei K, Otsuka H (1988) Macroregenerative nodule of the liver: a clinicopathologic study of 345 autopsy cases of chronic liver disease. Cancer 61:99–105

    PubMed  CAS  Google Scholar 

  • Galibert F, Mandart E, Fitoussi F, Tiollais P, Charnay P (1979) Nuleotide sequence of hepatitis B virus genome (subtype ayw) cloned inE. Coli. Nature 281:646–650

    PubMed  CAS  Google Scholar 

  • Ganem D, Varmus HE (1987) The molecular biology of the hepatitis B viruses. Annu Rev Biochem 56:651–693

    PubMed  CAS  Google Scholar 

  • Gerin JL (1990) Experimental WHV infection of woodchucks: an animal model of hepadnavirus-induced liver cancer. Gastroenterol Jpn 25 [Suppl 2]:38–42

    PubMed  Google Scholar 

  • Gherardi E, Gray J, Stoker M, Perryman M, Furlong R (1989) Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc Natl Acad Sci USA 86:5844–5848

    PubMed  CAS  Google Scholar 

  • Gilliam JH, Geisinger KR, Richter JE (1984) Primary hepatocellular carcinoma after chronic non-A, non-B post-transfusion hepatitis. Ann Intern Med 101:794–795

    PubMed  Google Scholar 

  • Gottesman M (1990) The role of proteases in cancer. Semin Cancer Biol 1:97–160

    Google Scholar 

  • Gray A, Tarn AW, Dull TJ, Hayflick J, Pintar J, Cavenee WK, Koufos A, et al (1987) Tissue-specific and developmentally regulated transcription of the insulin-like growth factor II gene. DNA 6:283–295

    PubMed  CAS  Google Scholar 

  • Grigoni WF, Garbisa S, D’Errico A, Baccarini P, Stetler-Stevenson WG, Liotta LA, Mancini I (1991) Evaluation of hepatocellular aggressiveness by a panel of extracellular matrix antigens. Am J Pathol 138:647–654

    Google Scholar 

  • Halevy O, Michalovitz D, Oren M (1990) Different tumor-derived p53 mutants exhibit distinct biological activities. Science 250:113–116

    PubMed  CAS  Google Scholar 

  • Hanahan D (1988) Dissecting multistep tumorigenesis in transgenic mice. Annu Rev Genet 22:479–519

    PubMed  CAS  Google Scholar 

  • Hayward NK, Walker GJ, Graham W, Cooksley E (1991) Hepatocellular carcinoma mutation. Nature 352:764

    PubMed  CAS  Google Scholar 

  • Held WA, Mullins JJ, Kuhn J, Gallagher JF, Gu GD, Gross KW (1989) T antigen expression and tumorigenesis in transgenic mice containing a mouse major urinary protein/SV40 T antigen hybrid gene. EMBO J 8:183–191

    PubMed  CAS  Google Scholar 

  • Hennessy C, Henry JA, May FEB, Westley BR, Angus B, Lennard TWJ (1992) Expression of the anti-metastatic gene nm23 in human breast cancer association with a good prognosis. J Natl Cancer Inst (in press)

  • Hess J, Stemler M, Will H, Schröder CH, Kuhn J, Braun R (1988) Frequent datection of antibodies to hepatitis B virus X-protein in acute, chronic and resolved infections. Med Microbiol Immunol 177:195–205

    PubMed  CAS  Google Scholar 

  • Hilger C, Velhagen I, Zentgraf H, Schröder CH (1991) Diversity of hepatitis B virus X-gene related transcripts in hepatocellular carcinoma a novel polyadenylation site on viral DNA. J Virol 65:4284–4291

    PubMed  CAS  Google Scholar 

  • Hino O, Shows TB, Rogler CE (1986) Hepatitis B virus integration site in hepatocellular carcinoma at chromosome 17; 18 translocation. Proc Natl Acad Sci USA 83:8338–8342

    PubMed  CAS  Google Scholar 

  • Hino O, Ohtake K, Rogler CE (1989) Features of two hepatitis B virus (HBV) DNA integrations suggest mechanism of HBV integration. J Virol 63:2638–2643

    PubMed  CAS  Google Scholar 

  • Höhne M, Schaefer S, Seifer M, Feitelson MA, Paul D, Gerlich WH (1990) Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus. EMBO J 11:1137–1145

    Google Scholar 

  • Hsu T, Möröy T, Etiemble J, Louise A, Trepo C, Tiollais P, Buendia M (1988) Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma. Cell 55:627–635

    PubMed  CAS  Google Scholar 

  • Hsu T, Fourel G, Etiemble J, Tiollais P, Buendia MA (1990) Integration of hepatitis virus DNA near c-myc in woodchuck hepatocellular carcinoma. Gastroenterol Jpn 25 [Suppl 2]: 43–48

    PubMed  Google Scholar 

  • Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427–428

    PubMed  CAS  Google Scholar 

  • Hu K-Q, Vierling JM, Siddiqui A (1990) Transactivation of HLADR gene by hepatitis B virus X gene product. Proc Natl Acad Sci USA 87:7140–7144

    PubMed  CAS  Google Scholar 

  • Huber BE, Dearfield KL, Williams CA, Heilmann CA, Thorgeirsson SS (1985) Tumorigenicity and transcriptional modulation of c-myc and N-ras oncogenes in a human hepatoma cell line. Cancer Res 45:4322–4329

    PubMed  CAS  Google Scholar 

  • Hunter T (1991) Cooperation between oncogenes. Cell 64:249–270

    PubMed  CAS  Google Scholar 

  • Hunter T, Pines J (1991) Cyclines and cancer. Cell 66:1071–1074

    PubMed  CAS  Google Scholar 

  • Hynes RO (1987) Integrins: a family of cell surface receptors. Cell 48:549–554

    PubMed  CAS  Google Scholar 

  • Imazeki F, Yagimuma K, Omata M, Okuda K, Kobayashi M, Koike K (1988) Integrated structures of duck hepatitis B virus DNA in hepatocellular carcinoma. J Virol 62:861–865

    PubMed  CAS  Google Scholar 

  • Infantolino D, Bonino F, Zanetti AR, Lesniewski RR, Barbazza R, Chiaramonte M (1990) Localization of hepatitis C virus (HCV) antigen by immunohistochemistry on fixed embedded liver tissue. Ital J Gastroenterol 22:198–199

    PubMed  CAS  Google Scholar 

  • Ishikawa F, Takaku F, Ochiai M, Hayashi K, Hirohashi S, Terada M, Takayama S, Nagao M, Sugimura T (1985) Biochem Biophys Res Commun 132:186–192

    PubMed  CAS  Google Scholar 

  • Ishikawa T, Kazuhiko U, Mangelsdorf DJ, Aburatani H, Stanger BZ, Shibasaki Y, Imawari M, Evans RM, Takaku F (1990) A functional retinoic acid receptor encoded by the gene on human chromosome 12. Mol Endocrinol 4:837–844

    PubMed  CAS  Google Scholar 

  • Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT (1990) TGFα overexpression in transgenic mice includes liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61:1137–1146

    PubMed  CAS  Google Scholar 

  • Kanai T, Hirohashi S, Upton MP, Nogudi M, Kishi K, Makunchi M, Yamasaki S, Hasegawa H, Takayasu K, Moriyama N, Shimosato Y (1987) Pathology of small hepatocellular carcinoma: a proposal for a new gross classification. Cancer 60:810–819

    PubMed  CAS  Google Scholar 

  • Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D (1991) Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66:1095–1104

    PubMed  CAS  Google Scholar 

  • Kaneko Y, Shibuya M, Nakayama T, Hayashida N, Toda G, Endo Y, Oka M, Oda T (1985) Hypomethylationof c-myc and epidermal growth factor receptor genes in human hepatocellular carcinoma and fetal liver. Jpn J Cancer Res 76:1136–1140

    PubMed  CAS  Google Scholar 

  • Kekule AS, Lauer U, Meyer M, Caselmann WH, Hofschneider PH, Koshy R (1990) The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 343:457–461

    PubMed  CAS  Google Scholar 

  • Kew MC, Houghton M, Choo QL, Kuo G (1990) Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet 335:873–874

    PubMed  CAS  Google Scholar 

  • Kiechle-Schwarz M, Scherer G, Kovacz G (1990) No evidence for loss of alleles at 11p in HBV negative hepatocellular carcinomas. Genes Chromosom Cancer 1:312–314

    PubMed  CAS  Google Scholar 

  • Kim CM, Koike K, Saito I, Myamura T, Jay G (1991) HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317–320

    PubMed  CAS  Google Scholar 

  • Kimura N, Johnson G (1983) Increased membrane associated nucleotide diphosphate kinase activity as a possible basis for enhanced guanine nucleotide dependent adenylate cyclase activity induced by picolinic acid treatment of simian virus 40-transformed normal rat kidney cells. J Biol Chem 258:12609–12617

    PubMed  CAS  Google Scholar 

  • Kimura Y, Hashimoto N, Kobayashi M, Higashi T, Watanabe A, Tsuji T (1990) Elevation of serum type IV collagen-degrading enzyme in hepatocellular carcinoma with metastasis. Clin Biochem 23:135–138

    PubMed  CAS  Google Scholar 

  • Kiyosawa K, Akahane Y, Nagata A, Furuta S (1984) Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis. Am J Gastroenterol 79:777–781

    PubMed  CAS  Google Scholar 

  • Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820–823

    PubMed  Google Scholar 

  • Koelma IA, Nap M, Huitema S, Kron RAF, Houthoff MJ (1986) Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters. Arch Pathol Lab Med 110:1035–1040

    PubMed  CAS  Google Scholar 

  • Kondo F, Hirooka N, Wada K, Kondo Y (1987) Morphological clues for the diagnosis of small hepatocellular carcinomas. Virchows Arch [A] 411:15–21

    CAS  Google Scholar 

  • Kondo F, Wada K, Nagato Y, Nakajima T, Kondo Y, Hirooka N, Ebara M, Ohto M, Okuda K (1989) Biopsy diagnosis of well differentiated hepatocellular carcinoma based on new morphologic criteria. Hepatology 9:751–755

    PubMed  CAS  Google Scholar 

  • Koshy R, Hofschneider PH (1984) In: Overby LR, Deinhardt F, Deinhardt J (eds) Viral hepatitis. Franklin Institute Press, Philadelphia, pp 205–210

    Google Scholar 

  • Koshy R, Zahm P, Wollersheim M, Hofschneider PH (1989) Transactivation by HBV X gene product. In: Bannasch P, Keppler D, Weber G (eds) Liver cell carcinoma. Kluwer Dordrecht, pp 117–135

    Google Scholar 

  • Lauer U, Weiß L, Hofschneider PH, Kekule AS (1991) Transcription factors AP-1, AP-2 and NFkB are mediators of the HBV preS/S (M HBs) transactivator effect. Hepatology 14:120A

    Google Scholar 

  • Lee DC, Rose TM, Webb NR, Todaro GJ (1985) Cloning and sequence analysis of a cDNA for rat transforming growth factor-α. Nature 313:489–491

    PubMed  CAS  Google Scholar 

  • Lee T-H, Finegold MJ, Shen R-F, DeMayo J, Woo SSLC, Butel JS (1990) Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol 64:5939–5947

    PubMed  CAS  Google Scholar 

  • Lefkovitch JH, Apfelbaum TF (1987) Liver cell dysplasia and hepatocellular carcinoma in non-A, non-B hepatitis. Arch Pathol Lab Med 111:170–173

    Google Scholar 

  • Levin EG, Santell L (1987) Association of plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells. J Cell Biol 105:2543–2649

    PubMed  CAS  Google Scholar 

  • Levine AJ, Momand J, Finlay CA (1991) The p53 tumor suppressor gene. Nature 351:453–455

    PubMed  CAS  Google Scholar 

  • Lewin B (1991) Oncogenic conversion by regulatory changes in transcription factors. Cell 64:303–312

    PubMed  CAS  Google Scholar 

  • Liang X-H, Stemler M, Will H, Braun R, Tang Z-Y, Schröder CH (1988) Low incidence and high titers of antibodies to hepatitis B virus X protein in sera of Chinese patients with hepatocellular carcinoma. J Med Virol 25:329–337

    PubMed  CAS  Google Scholar 

  • Lieber CS, Garro A, Leo MA, Mak KM, Werner T (1986) Alcohol and cancer. Hepatology 8:531–532

    Google Scholar 

  • Limmer J, Fleig WE, Leupold D, Bittner R, Ditschuneit H, Beger HG (1988) Hepatocellular carcinoma in type I glycogen storage disease. Hepatology 8:531–537

    PubMed  CAS  Google Scholar 

  • Liotta LA, Mandler R, Murano G, Katz DA, Gordon RK, Chiang PK, Schiffmann E (1986) Tumor cell autocrine motility factor. Proc Natl Acad Sci USA 83:3302–3306

    PubMed  CAS  Google Scholar 

  • Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: an inbalance of positive and negative regulation. Cell 64:327–336

    PubMed  CAS  Google Scholar 

  • Makino R, Hayashi K, Sato S, Sugimura T (1984) Expression of the c-H-ras andc-myc genes in rat liver tumors. Biochem Biophys Res Commun 119:1092–1102

    PubMed  CAS  Google Scholar 

  • Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233–1238

    PubMed  CAS  Google Scholar 

  • Mansouri A, Spurr N, Goodfellow PN, Kemler R (1988) Characterization and chromosomal localization of the gene encoding the human cell adhesion molecule uvomorulin. Differentiation 38:67–71

    PubMed  CAS  Google Scholar 

  • Marion PL, Oshiro LS, Regnery DC, Scullard GH, Robinson WS (1980) A virus in Beechey ground squirrels that is related to hepatitis B virus of humans. Proc Natl Acad Sci USA 77:2941–2945

    PubMed  CAS  Google Scholar 

  • Marion PL, Van Davelaar MJ, Knight SS, Salazar FH, Garcia G, Popper H, Robinson WS (1986) Hepatocellular carcinoma in ground squirrel persistently infected with ground squirrel hepatitis virus. Proc Natl Acad Sci USA 83:4543–4546

    PubMed  CAS  Google Scholar 

  • Marshall CJ (1991) Tumor suppressor genes. Cell 64:313–326

    PubMed  CAS  Google Scholar 

  • Mason WS, Seal G, Summers J (1980) Virus of Peking ducks with structural and biological relatedness to human hepatitis B virus. J Virol 36:829–836

    PubMed  CAS  Google Scholar 

  • Mathieu M, Rochefort H, Barentow B, Prebois C, Vignon F (1990) Interaction of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/Mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. Mol Endocrinol 4:1327–1335

    PubMed  CAS  Google Scholar 

  • Matrisian L, Bowden T (1990) Stromelysin/transin and tumor progression. Semin Cancer Biol 1:107–115

    PubMed  CAS  Google Scholar 

  • Matsubara K, Tokino T (1990) Integration of hepatitis B virus DNA and its implication for hepatocarcinogenesis. Mol Biol Med 7:243–260

    PubMed  CAS  Google Scholar 

  • Matsuno Y, Hirohashi S, Furuya SW, Sakamoto M, Mukai K, Shimosato Y (1990) Heterogeneity of proliferative activity in nodule-in-nodule lesions of small hepatocellular carcinoma. Acta Pathol Jpn 40:267–278

    Google Scholar 

  • McMahon G, Hanson L, Lee J-J, Wogan GN (1986) Identification of an activated c-Ki-ras oncogene in rat liver tumors induced by aflatoxin B1. Proc Natl Acad Sci USA 83:9418–9422

    PubMed  CAS  Google Scholar 

  • McMahon G, Davis E, Wogan GN (1987) Characterization of c-Ki-ras oncogene alleles by direct sequencing of enzymatically amplified DNA from carcinogen-induced tumors. Proc Natl Acad Sci USA 84:4974–4978

    PubMed  CAS  Google Scholar 

  • McMahon G, Davis EF, Huber LJ, Kim Y, Wogan GN (1990) Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors. Proc Natl Acad Sci USA 87:1104–1108

    PubMed  CAS  Google Scholar 

  • Mead JE, Fausto N (1989) Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA 86:1558–1562

    PubMed  CAS  Google Scholar 

  • Messing A, Chen Y, Palmiter RD, Brinster RL (1985) Peripheral neuropathies, hepatocellular carcinomas and islet cell adenomas in transgenic mice. Nature 316:461–463

    PubMed  CAS  Google Scholar 

  • Milner J, Cook A, Mason J (1990) p53 is associated with p34/cdc2 in transformed cells. EMBO J 9:2885–2889

    PubMed  CAS  Google Scholar 

  • Morizane T, Nakamura H, Saito H, Watanabe T, Inagaki Y, Satoh I, Tsuchimoto K, Tsuchiya M (1987) Transformation of NIH/ 3T3 cells by DNA from a human hepatoma cell line with integrated hepatitis B virus DNA. Eur J Cancer Clin Oncol 23:163–169

    PubMed  CAS  Google Scholar 

  • Möröy T, Marchio A, Etiemble J, Trepo C, Tiollais P, Buendia MA (1986) Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks. Nature 324:276–297

    PubMed  Google Scholar 

  • Nagasue N, Akamizu Y, Yukaya H, Yuuki I (1984) Hepatocellular pseudotumor in the cirrhotic liver. Cancer 54:2487–2494

    PubMed  CAS  Google Scholar 

  • Nagaya T, Nakamura T, Tokino T, Tsurimoto T, Imai M, Mayumi T, Kamino K, Yamamura K, Matsubara K (1987) The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinomas. Genes Dev 1:773–782

    PubMed  CAS  Google Scholar 

  • Nagy P, Evarts RP, Marsden E, Roach J, Thorgeirsson SS (1988) Cellular distribution of c-myc transcripts during chemical hepatocarcinogenesis. Cancer Res 48:5522–5527

    PubMed  CAS  Google Scholar 

  • Nakamura T, Tokino T, Nagaya T, Matsubara K (1988) Microdeletion associated with the integration process of hepatitis B virus DNA. Nucleic Acids Res 16:4865–4873

    PubMed  CAS  Google Scholar 

  • Nakanuma Y, Terada T, Terasaki S, Ueda K, Nonomura A, Kawahara E, Matsui O (1990) Atypical adenomatous hyperplasia in liver cirrhosis: low grade hepatocellular carcinoma or borderline lesion? Histopathology 17:27–35

    PubMed  CAS  Google Scholar 

  • Nambu S, Inone K, Sasaki H (1987) Site-specific hypomethylation of the c-myc oncogene in human hepatocellular carcinoma. Jpn J Cancer Res 78:695–704

    PubMed  CAS  Google Scholar 

  • Nickerson J, Wells W (1984) The microtubule-associated nucleoside diphosphate kinase. J Biol Chem 259:11297–11304

    PubMed  CAS  Google Scholar 

  • Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G (1985) Survival and causes of death in cirrhotic and noncirrhotic patients with primary hemochromatosis. N Engl J Med 313:1256–1262

    PubMed  CAS  Google Scholar 

  • Ochiya T, Fujiyama A, Fukushige S, Hatada I, Matsubara K (1986) Molecular cloning of an oncogene from a human hepatocellular carcinoma. Proc Natl Acad Sci USA 83:4993–4997

    PubMed  CAS  Google Scholar 

  • Ochiya T, Tsurimoto T, Ueda K, Okubo K, Shiozawa M, Matsubara K (1989) An in vitro system for infection with hepatitis B virus that uses primary human hepatocytes. Proc Natl Acad Sci USA 86:1875–1879

    PubMed  CAS  Google Scholar 

  • Ogata N, Kamimura T, Asakura H (1991) Point mutation, allelic loss and increased methylation of c-Ha-ras gene in human hepatocellular carcinoma. Hepatology 13:31–37

    PubMed  CAS  Google Scholar 

  • Ogston CW, Jonak GJ, Rogler CE, Astrin SM, Summers J (1982) Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from hepatocellular carcinomas of woodchucks. Cell 29:385–394

    PubMed  CAS  Google Scholar 

  • Ohbayashi A (1976) Genetic and familial aspects of liver cirrhosis and hepatocellular carcinoma. In: Okuda K, Peters RL (eds) Hepatocellular carcinoma. Wiley, New York, pp 43–51

    Google Scholar 

  • Ohno Y, Shiga J, Machinami R (1990) A histopathological analysis of five cases of adenomatous hyperplasia containing minute hepatocellular carcinoma. Acta Pathol Jpn 40:267–278

    PubMed  CAS  Google Scholar 

  • Okamoto H, Tsuda F, Mayumi M (1987) Defective mutants of hepatitis B virus in the circulation of symptom-free carriers. Jpn J Exp Med 54:217–221

    Google Scholar 

  • Okamoto T, Katada T, Murayama Y, Ui M, Ogata E, Nishimoto I (1990) A simple structure encodes G protein activating function of the IGF-II/mannose-6-phosphate receptor. Cell 62:709–717

    PubMed  CAS  Google Scholar 

  • Okubo K, Nakamura T, Tokino T, Matsubara K (1990) Different type of hepatitis B virus (HBV) DNA integrants that may reflect the integration process. Gastroenterol Jpn 25 [Suppl 2]:23–30

    Google Scholar 

  • Pasquinelli C, Garreau F, Bougueleret L, Cariani E, Grzeschik KH, Thiers V, Croissant O, Hadchouel M, Tiollais P, Brechot C (1988) Rearrangement of a common cellular DNA domain on chromosome 4 in human primary liver tumors. J Virol 62:629–632

    PubMed  CAS  Google Scholar 

  • Pasquinelli C, Bhavani K, Chisari FV (1992) Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice. Cancer Res 52:2823–2829

    PubMed  CAS  Google Scholar 

  • Peters RL (1976) Pathology of hepatocellular carcinoma: In: Okuda K, Peters RL (eds) Hepatocellular carcinoma. Wiley New York, pp 107–168

    Google Scholar 

  • Pinhasi-Kimki O, Michalovitz D, Ben-Zeev A, Oren M (1986) Specific interaction between the p53 cellular tumor antigen and major heat shock proteins. Nature 320:182–185

    Google Scholar 

  • Popper H, Roth L, Purcell R, Tennant BC, Gerin JL (1987) Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc Natl Acad Sci USA 84:866–870

    PubMed  CAS  Google Scholar 

  • Rao C, Castronovo V, Schmitt MC, Wewer U, Claysmith A, Liotta LA, Sobel M (1989) Evidence for a precursor of the high-affinity metastasis associated murine laminin receptor. Biochemistry 28:7476–7486

    PubMed  CAS  Google Scholar 

  • Rechler M, Mad S, Nissley P (1985) The nature and regulation of the receptors for insulin-like growth factors. Annu Rev Physiol 47:425–442

    PubMed  CAS  Google Scholar 

  • Reich R, Thompson E, Iwamoto Y, Martin GR, Deason JR, Fuller GC, Miskin R (1988) Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 48:3307–3312

    PubMed  CAS  Google Scholar 

  • Resnick RH, Stone K, Antonioli D (1983) Primary hepatocellular carcinoma following non-A, non-B posttransfusion hepatitis. Dig Dis Sci 28:908–911

    PubMed  CAS  Google Scholar 

  • Reynolds HR, Stowers SJ, Maronpot RR, Anderson MW, Aaronson SA (1986) Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors in the B6C3F1 mouse. Proc Natl Acad Sci USA 83:33–37

    PubMed  CAS  Google Scholar 

  • Reynolds SH, Stowers SJ, Patterson RM, Maronpot RR, Aaronson SA, Anderson MW (1987) Activated oncogenes in B6C3F1 mouse liver tumors: implications of risk assessment. Science 237:1309–1316

    PubMed  CAS  Google Scholar 

  • Richmond RE, Pereira MA, Carter JH, Long RE (1988) Quantitative and qualitative immunohistochemical detection ofmyc andsrc oncogene proteins in normal, nodule and neoplastic liver. J Histochem Cytochem 36:179–184

    PubMed  CAS  Google Scholar 

  • Rogler CE, Summers J (1982) Novel form of woodchuck hepatitis virus DNA isolated from chronically infected woodchuck liver nuclei. J Virol 44:852–863

    PubMed  CAS  Google Scholar 

  • Rogler CE, Summers J (1984) Cloning and structural analysis of integrated woodchuck hepatitis virus DNA sequences from a chronically infected liver. J Virol 50:832–837

    PubMed  CAS  Google Scholar 

  • Rogler CE, Sherman M, Su CY, Shafritz DA, Summers J, Shows TB, Henderson A, Kew M (1985) Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma. Science 230:319–322

    PubMed  CAS  Google Scholar 

  • Ryan AJ, O’Conner P, Billett MA (1988) Increased oncogene expression in livers of rats after exposure to dimethylnitrosamine. Biochem Soc Trans 16:1058–1059

    CAS  Google Scholar 

  • Sakamoto M, Hirohashi S, Tsuda H, Ino Y, Shimosato Y, Yamasaki S, Makuuchi M, Hasegawa H, Terada M, Hosoda Y (1988) Increasing incidence of hepatocellular carcinoma possibly associated with non-A, non-B hepatitis in Japan, disclosed by hepatitis B virus DNA analysis of surgically resected cases. Cancer Res 15:7294–7297

    Google Scholar 

  • Sakamoto M, Hirohashi S, Shimosato Y (1991) Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 22:172–178

    PubMed  CAS  Google Scholar 

  • Sandgren EP, Quaife CJ, Pinkert CA, Palmiter RD, Brinster RL (1989) Oncogene induced liver neoplasia in transgenic mice. Oncogene 4:715–724

    PubMed  CAS  Google Scholar 

  • Schirmacher P, Held WA, Yang D, Biempica L, Rogler CE (1991) Selective amplification of periportal transitional cells precedes formation of hepatocellular carcinoma in SV40 large Tag transgenic mice. Am J Pathol 139:231–241

    PubMed  CAS  Google Scholar 

  • Schirmacher P, Held WA, Chisari FV, Rustum Y, Wang H-P, Yang D, Rogler CE (1992 a) Reactivation of insulinlike growth factor-II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. Cancer Res 52:2549–2556

    PubMed  CAS  Google Scholar 

  • Schirmacher P, Geerts A, Pietrangelo A, Dienes HP, Rogler CE (1992 b) Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast like cells derived from fat-storing cells. Hepatology 15:5–11

    PubMed  CAS  Google Scholar 

  • Schlicht H-J, Esser A, Bartenschlager R, Galle P, Kuhn C, Nassal M, Niepmann M, Radziwill G, Schaller H (1989) Unravelling the life cycle of hepatitis B viruses. In: Bannasch P, Keppler D, Weber G (eds) Liver cell carcinoma. Kluwer, Dordrecht, pp 79–91

    Google Scholar 

  • Schreiber A, Winkler HE, Derynck R (1986) Transforming growth factor-α is a more potent angiogenic mediator than epidermal growth factor. Science 232:2228–2232

    Google Scholar 

  • Schröder CM, Zentgraf H (1990) Hepatitis B virus related hepatocellular carcinoma: chronicity of infection the opening to different pathways of malignant transformation. Biochem Biophys Acta 1032:137–156

    PubMed  Google Scholar 

  • Schuermann M, Neuberg M, Hunter JB, Jennwein T, Ryseck R-P, Bravo R, Müller R (1989) The leucine repeat motif infos protein mediates complex formation with jun/AP-1 and is required for transformation. Cell 56:507–516

    PubMed  CAS  Google Scholar 

  • Seeger C, Baldwin B, Hornbuckle WE, Yeager AE, Tennant BC, Cote P, Ferrell L, Ganem D, Varmus HE (1991) Woodchuck Hepatitis Virus is a more efficient oncogenic agent than ground squirrel hepatitis virus in a common host. J Virol 65:1673–1679

    PubMed  CAS  Google Scholar 

  • Seifer M, Höhne M, Schaefer S, Gerlich WH (1991) In vitro tumorigenicity of hepatitis B virus DNA and Hbx protein. J Hepatol 13:S61-S65

    PubMed  CAS  Google Scholar 

  • Seki S, Sakaguchi H, Kawakita N, Yanai A, Kim K, Mizoguchi Y, Kobayashi K (1990) Identification and fine structure of proliferating hepatocytes in malignant and nonmalignant liver diseases by use of a monoclonal antibody against DNA polymerase alpha. Hum Pathol 21:1020–1030

    PubMed  CAS  Google Scholar 

  • Sell S, Hunt JM, Knoll BJ, Dunsford HA (1987) Cellular events during hepatogenesis in rats and the question of premalignancy. Adv Cancer Res 48:37–111

    PubMed  CAS  Google Scholar 

  • Sepulveda AR, Finegold MJ, Smith B, Slagle BL, DeMayo JL, Shen RF, Woo SL, Butel JS (1989) Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV-40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene. Cancer Res 49:6108–6117

    PubMed  CAS  Google Scholar 

  • Seto E, Yen TS, Peterlin BM, Ou JM (1988) Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc Natl Acad Sci USA 85:8286–8290

    PubMed  CAS  Google Scholar 

  • Seto E, Mitchell PJ, Yen TSB (1990) Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature 344:72–74

    PubMed  CAS  Google Scholar 

  • Sever CE, Locker J (1991) Expression of retinoic acid alpha and beta receptor genes in liver and hepatocellular carcinoma. Mol Carcinog 4:138–144

    PubMed  CAS  Google Scholar 

  • Shapiro ET, Bell GI, Polonsky KS, Rubenstein AH, Kew MC, Tager HS (1990) Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II. J Clin Invest 85:1672–1679

    PubMed  CAS  Google Scholar 

  • Shih C, Burke K, Chou M-J, Zeldis JB, Yang CS, Lee CS, Isselbacher KJ, Wands JR, Goodman HM (1987) Tight clustering of human hepatitis B virus integration sites in hepatomas near a triple-stranded region. J Virol 61:3491–3498

    PubMed  CAS  Google Scholar 

  • Shimoyama Y, Hirohashi S (1991) Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett 57:131–135

    PubMed  CAS  Google Scholar 

  • Shirakata Y, Kawada M, Fujiki Y, Sano H, Oda M, Yaginuma K, Kobayashi M, Koike K (1989) The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn J Cancer Res 80:617–621

    PubMed  CAS  Google Scholar 

  • Sinha S, Webber C, Marshall LJ, Knowles MA, Proctor A, Barras NC, Neal GE (1988) Activation ofras oncogene in aflatoxininduced rat liver carcinogenesis. Proc Natl Acad Sci USA 85:3673–3677

    PubMed  CAS  Google Scholar 

  • Slagle BL, Zhou YZ, Butel JS (1991) Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res 51:49–54

    PubMed  CAS  Google Scholar 

  • Soares MB, Ishii DN, Efstratiadis A (1985) Development and tissue-specific expression of a family of transcripts related to rat insulin-like growth factor II mRNA. Nucleic Acids Res 14:1129–1134

    Google Scholar 

  • Sogaard PE (1981) Nodular transformation of the liver, alphafetoprotein, and hepatocellular carcinoma. Hum Pathol 12:1052

    PubMed  CAS  Google Scholar 

  • Spandau DF, Lee CH (1988) Trans-activation of viral enhancers by the hepatitis B virus X protein. J Virol 62:427–434

    PubMed  CAS  Google Scholar 

  • Sprengel R, Kaleta EF, Will H (1988) Isolation and characterization of a hepatitis B virus endemic in herons. J Virol 62:3832–3839

    PubMed  CAS  Google Scholar 

  • Srivastava S, Zou Z, Pirollo K, Blattner W, Chang EH (1990) Germ-line transmission of a mutated p53 gene in a cancer prone family with Li-Fraumeni Syndrome. Nature 348:747–749

    PubMed  CAS  Google Scholar 

  • Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, Sobel ME (1988) Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80:200–204

    PubMed  CAS  Google Scholar 

  • Strom SC, Faust JB (1990) Oncogene activation and hepatocarcinogenesis. Pathobiology 58:153–167

    PubMed  CAS  Google Scholar 

  • Stromeyer FW, Ishak KG (1981) Nodular transformation (nodular “regenerative” hyperplasia) of the liver. Hum Pathol 12:60–70

    PubMed  CAS  Google Scholar 

  • Summers J, Smolec JM, Snyder R (1978) A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci USA 75:4533–4537

    PubMed  CAS  Google Scholar 

  • Szmuness W (1978) Hepatocellular carcinoma and the hepatitis B virus: evidence for causal association. Prog Med Virol 24:40–69

    PubMed  CAS  Google Scholar 

  • Takada S, Koike K (1989) Activated N-ras gene was found in human hepatoma tissue but only in a small fraction of tumor cells. Oncogene 4:189–193

    PubMed  CAS  Google Scholar 

  • Takada S, Koike K (1990) Trans-activation function of 3′-truncated X gene as an X-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues. Proc Natl Acad Sci USA 87:5628–5632

    PubMed  CAS  Google Scholar 

  • Takada S, Gotoh Y, Hayashi S, Yoshida M, Koike K (1990) Structural rearrangement of integrated hepatitis B virus DNA as well as cellular flanking DNA is present in chronically infected hepatic tissues. J Virol 64:822–828

    PubMed  CAS  Google Scholar 

  • Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Okazaki N, Takayasu Y, Kosuge T, Motoo Y, Yamazaki S, Hasegawa H (1990) Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 336:1150–1153

    PubMed  CAS  Google Scholar 

  • Tashiro F, Morimura S, Hayashi K, Makino R, Kawanura H, Horikoshi N, Nemoto K, Ohtsubo K, Sugimura T, Weno Y (1986) Expression of the c-Ha-ras and c-myc genes in aflatoxin Bl-induced hepatocellular carcinomas. Biochem Biophys Res Commun 138:858–864

    PubMed  CAS  Google Scholar 

  • Templeton NS, Brown PD, Levy AT, Margulies IMK, Liotta LA, Stetler-Stevenson WG (1990) Cloning and characterization of human tumor cell interstitial collagenase. Cancer Res 50:5431–5437

    PubMed  CAS  Google Scholar 

  • Thorgeirsson UP, Liotta LA, Kalebic T, Marguiles IM, Thomas K, Rios-Calderone M, Russo RG (1982) Effect of natural protease inhibitors and a chemoattractant on tumor cell invasionin vitro. J Natl Cancer Inst69:1049–1054

    PubMed  CAS  Google Scholar 

  • Tokino T, Fukushige S, Nakamura T, Nagaya T, Murotsu T, Shiga K, Aoki N, Matsubara K (1987) Chromosomal translocation and inverted duplication associated with integrated hepatitis B virus in hepatocellular carcinoma. J Virol 61:3848–3854

    PubMed  CAS  Google Scholar 

  • Torimura T, Ueno T, Inuzuka S, Tanaka M, Abe H, Tanikawa K (1991) Mechanism of fibrous capsule formation surrounding hepatocellular carcinoma. Immunohistochemical study. Arch Pathol Lab Med 115:365–371

    PubMed  CAS  Google Scholar 

  • Treinin M, Laub O (1987) Identification of a promoter element located upstream from the hepatitis B virus gene. Mol Cell Biol 7:545–548

    PubMed  CAS  Google Scholar 

  • Tsuda H, Hirohashi S, Shimosato Y, Terada M, Hasegawa H (1988) Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma. Gastroenterology 95:1664–1666

    PubMed  CAS  Google Scholar 

  • Tsuda H, Zhang WD, Shimosato Y, Yokota J, Terada M, Sugimura T, Miyamura T, Hirohashi S (1990) Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 87:6791–6794

    PubMed  CAS  Google Scholar 

  • Twu JS, Schloemer RH (1987) Transcriptional trans-activating function of hepatitis B virus. J Virol 61:3448–3453

    PubMed  CAS  Google Scholar 

  • Twu JS, Rosen CA, Haseltine WA, Robinson WS (1989) Identification of a region within the human immunodeficiency virus type I long terminal repeat that is essential for transactivation by the hepatitis B virus gene X. J Virol 63:2857–2860

    PubMed  CAS  Google Scholar 

  • Uneo T, Takahashi K, Matsuguchi T, Ikejiri K, Endo H, Yamamoto M (1988) Reactivation of rat insulin-like growth factor II gene during hepatocarcinogenesis. Carcinogenesis 9:1779–1783

    Google Scholar 

  • Vorce RL, Goodman JI (1989) Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors. J Mol Toxicol 2:99–116

    CAS  Google Scholar 

  • Wada K, Kondo F, Kondo Y (1988) Large regenerative nodules and dysplastic nodules in cirrhotic livers: a histopathological study. Hepatology 6:1684–1688

    Google Scholar 

  • Walker GJ, Hayward NK, Falvey S, Cooksley WG (1991) Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res 51:4367–4370

    PubMed  CAS  Google Scholar 

  • Wang HP, Rogler CE (1988) Deletions in chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet Cell Genet 48:72–78

    PubMed  CAS  Google Scholar 

  • Wang HP, Rogler CE (1991) Topoisomerase I-mediated integration of hepadnavirus DNA in vitro. J Virol 65:2381–2392

    PubMed  CAS  Google Scholar 

  • Wang J, Chenivesse X, Henglein B, Brechot C (1990) Hepatitis B virus-integration in a cyclin A gene in a hepatocellular carcinoma. Nature 348:555–557

    Google Scholar 

  • Watanabe S, Okita K, Harada T, Kodama T, Numa Y, Takemoto T, Takahashi M (1983) Morphologic studies of the liver cell dysplasia. Cancer 51:2197–2205

    PubMed  CAS  Google Scholar 

  • Weidner KM, Arakaki N, Hartmann G, Vandekerckhove J, Weinhart S, Rieder H, Fonatsch C, Tsubouchi H, Hishida T, Daikuhara Y, Birchmeier W (1991) Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 88:7001–7005

    PubMed  CAS  Google Scholar 

  • Weinberg RA (1991) Tumor suppressor genes. Science 254:1138–1146

    PubMed  CAS  Google Scholar 

  • Weinberg AG, Mize CE, Worthan HG (1976) The occurrence of hepatoma in the chronic form of hereditary tyrosinaemia. J Pediatr 88:434–438

    PubMed  CAS  Google Scholar 

  • Wilkinson ML, Portmann B, Williams R (1983) Wilson’s disease and hepatocellular carcinoma: possible protective role of copper. Gut 24:767–771

    PubMed  CAS  Google Scholar 

  • Wiseman RW, Stowers SJ, Miller EC, Anderson MW, Miller JA (1986) Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3F1 mouse. Proc Natl Acad Sci USA 83:5825–5829

    PubMed  CAS  Google Scholar 

  • Wollersheim M, Debelka U, Hofschneider PH (1988) A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene 3:545–552

    PubMed  CAS  Google Scholar 

  • Wu JY, Zhou Z-Y, Judd A, Cartwright CA, Robinson WS (1990) The hepatitis B virus-encoded transcriptional trans-activator hbx appears to be a novel protein serine/threonine kinase. Cell 63:687–695

    PubMed  CAS  Google Scholar 

  • Yang DY, Rogler CE (1991) Analysis of insulin-like growth factor II (IGF-II) expression in neoplastic nodules and hepatocellular carcinomas of woodchucks utilizingin situ hybridization and immunohistochemistry. Carcinogenesis 12:1893–1901

    PubMed  CAS  Google Scholar 

  • Yang SS, Zhang K, Viera W, Taub JV, Zeilstra-Ryalls JH, Sommerville RL (1990) A human hepatocellular carcinoma 3.0 kilobase DNA sequence transforms both rat liver cells and NIH3T3 fibroblasts and encodes a 52 kilodalton protein. Cancer Res 50:S5658-S5667.

    Google Scholar 

  • Yang D, Schirmacher P, Held WA, Rogler CE (1991) Growth factors, oncogenes, tumor suppressor genes and carcinogenic mechanisms in the liver. In: Hollinger FB, Lemon SM, Margolis HS (eds) Viral hepatitis and liver disease. Williams and Wilkins, Baltimore, pp 547–556

    Google Scholar 

  • Yeh YC, Tsai JF, Chuang LY, Yeh MW, Tsai JH, Florine DL, Tarn JP (1987) Elevation of transforming growth factor α and its relationship to the epidermal growth factor and α-fetoprotein levels in patients with hepatocellular carcinoma. Cancer Res 47:896–901

    PubMed  CAS  Google Scholar 

  • Yu MC, Tong MJ, Coursaget P, Ross RK, Govindarajan S, Henderson BE (1990) Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 82:1038–1041

    PubMed  CAS  Google Scholar 

  • Zhou YZ, Slagle BL, Donehower LA, Van Tuinen PV, Ledbetter DH, Butel JS (1988) Structural analysis of hepatitis B virus genome integrated into chromosome 17p of an human hepatocellular carcinoma. J Virol 62:4224–4231

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schirmacher, P., Rogler, C.E. & Dienes, H.P. Current pathogenetic and molecular concepts in viral liver carcinogenesis. Virchows Archiv B Cell Pathol 63, 71–89 (1993). https://doi.org/10.1007/BF02899246

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02899246

Key words

Navigation